Prognostic value of CD44 expression in patients with hepatocellular carcinoma: meta-analysis

BACKGROUND: CD44 has been reported to be involved with tumor growth and metastasis and has also been implicated as a CSC marker in hepatocellular carcinoma (HCC). However, the prognostic value of CD44 still remains controversial; hence, we investigated the correlation between CD44 and the clinicopat...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Yangkun, Tan, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912706/
https://www.ncbi.nlm.nih.gov/pubmed/27330410
http://dx.doi.org/10.1186/s12935-016-0325-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4912706/
https://www.ncbi.nlm.nih.gov/pubmed/27330410
http://dx.doi.org/10.1186/s12935-016-0325-2

Ejemplares similares